Biological Response Modifier Therapy

Known as: Biotherapy, Biologics Therapies, Biological Response Modifiers Therapy 
A form of treatment that implies the administration of substances which produce a biological reaction in the organism thus enhancing or restoring the… (More)
National Institutes of Health

Related topics

Related topics

27 relations

Narrower (11)

Allogeneic Hematopoietic Stem Cell TransplantationBlood TransfusionImmunizationImmunotherapy
(More)
Graft versus host disease prophylaxis/therapyOncolytic VirotherapyVaccine Therapyanti-cytokine therapy
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Biologic therapies and bone loss in rheumatoid arthritis
Rheumatoid arthritis (RA) is a common systemic autoimmune disease of unknown cause, characterized by a chronic, symmetric, and… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2013
Review
2013
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
Currently, five anti-TNF biologic agents are approved for the treatment of rheumatoid arthritis (RA): adalimumab, infliximab… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management Axel… (More)
Is this relevant?
Review
2012
Review
2012
Th17 cells in immunity to Candida albicans.
Our understanding of immunity to fungal pathogens has advanced considerably in recent years. Particularly significant have been… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.
Tomohisa Seki,1,7 Shinsuke Yuasa,1,2,7 Mayumi Oda,2 Toru Egashira,1 Kojiro Yae,1 Dai Kusumoto,1 Hikari Nakata,1 Shugo Tohyama,1… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2009
Review
2009
Biological therapies for inflammatory bowel diseases.
Crohn's disease and ulcerative colitis are chronic disabling inflammatory bowel diseases (IBDs). Although the causes of IBD are… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on…
OBJECTIVE Tuberculosis (TB) is associated with anti-tumor necrosis factor (anti-TNF) monoclonal antibody (mAb) therapy, but… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Synergistic antitumor effects of immune cell-viral biotherapy.
Targeted biological therapies hold tremendous potential for treatment of cancer, yet their use has been limited by constraints on… (More)
Is this relevant?
Review
2004
Review
2004
The diagnosis and medical management of advanced neuroendocrine tumors.
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endocrine glands such as the… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
UNLABELLED The aim of this prospective phase II study was to evaluate the tumor response of neuroendocrine tumors to high-dose… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?